BMW's Summer of Strain: Recalls, Restructuring, and a Sharply Reduced Outlook
Published on 08/04/2026 at 22:31 | Redaktion boerse-global.de
The second quarter of 2026 will go down as one of the most punishing periods in BMW's recent corporate history. The Munich-based automaker reported a 35.1 percent collapse in pre-tax profit to EUR 1.697 billion, with net income falling by a third to EUR 1.2 billion. Group revenue slipped 8 percent to EUR 31.3 billion. The figures, released on July 30, confirmed what many in the market had already suspected: the company's core automobile division is bleeding margin at an alarming rate. The segment's EBIT margin tumbled to 2.3 percent from 5.4 percent a year earlier, prompting management to reaffirm its already-reduced full-year guidance of just 1 to 3 percent—a far cry from the 4 to 6 percent originally promised.
A Recall Wave Compounds the Operational Pain
The earnings disappointment arrived alongside a fresh quality crisis. BMW issued a global recall covering 744,234 vehicles from model years 2020 through 2026, citing fire risk from deposits accumulating in starter relays. The affected lineup spans nearly the entire range—from the 2-series through the 7-series, plus the X5, Z4, and the all-electric i3. In Germany alone, roughly 42,300 vehicles are affected. The company's motorcycle division also issued a separate recall for the S 1000 RR model over issues with the engine, ABS, and lighting systems.
The recall wave comes on the heels of a legal resolution that had been pending since 2025. BMW reached a settlement with supplier Aumovio—formerly a Continental division—over damages claims tied to a major 2024 recall. For Aumovio, the agreement forced a cut to its own forecast. For BMW, it closes a chapter of legal overhang, though it does little to address the immediate operational headwinds.
Deep Cost Cuts Under New Leadership
The deteriorating financial picture has accelerated structural changes at the top of the organization. Under newly installed CEO Milan Nedeljkovic, BMW announced on July 29 a global workforce restructuring program: approximately 8,000 positions—about 5 percent of the workforce—are slated for elimination by the end of 2027. According to reports, the reductions will be achieved primarily through voluntary programs targeting administration and development roles in Germany. The supervisory board has also approved the appointment of Dorothea von Boxberg to the management board effective September 1.
These moves carry their own costs. Goldman Sachs, which maintained its buy recommendation, trimmed its price target from EUR 84 to EUR 82, citing higher provisions for severance payments tied to the job cuts. The restructuring is widely viewed as necessary, but it adds near-term financial pressure to a company already grappling with weak demand in China—the primary factor behind the lowered guidance.
While BMW's restructuring touches thousands of roles, many UK employers face their own set of compliance obligations that carry serious legal weight. The Health & Safety at Work Act 1974 places duties on directors and managers that, if breached, can lead to personal liability and substantial fines. A free toolkit with 9 ready-to-use tools—including risk assessments, checklists, and a directors' liability guide—helps you close compliance gaps before they become costly problems. Download the free Health & Safety at Work Act 1974 Toolkit
Analysts Split on Valuation as Shares Languish
The analyst community has responded with a mix of caution and selective optimism. DZ Bank downgraded BMW from "Buy" to "Hold" and cut its fair value from EUR 75.00 to EUR 65.00, pointing to the weak China business and a lack of near-term catalysts. RBC Capital Markets maintained its "Sector Perform" rating with a price target of EUR 62.00, with analyst Tom Narayan noting that investor attention is shifting toward the capital markets day scheduled for late September, where management is expected to outline its strategic repositioning in greater detail.
Other houses have adjusted their targets downward in recent days while largely keeping buy or hold ratings, with price objectives ranging between EUR 70 and EUR 90. The divergence in views reflects genuine uncertainty about how quickly BMW can arrest the decline.
The share price tells its own story. The stock has lost 35.37 percent since the start of the year and currently trades around EUR 60, having slipped below the price targets of both DZ Bank and RBC. It sits roughly 7 percent above its 52-week low from July 24—a sign that the pace of selling has moderated, though a sustained recovery has yet to materialize.
A Simplified Share Structure and a Pending Strategic Reckoning
On the capital side, BMW has completed one significant structural step: the conversion of all preferred shares into common shares, finalized on June 30. The preferred shares saw their last day of trading on that date, concluding a process initiated in May.
For investors, the picture that emerges is one of compounding pressures—a deteriorating earnings base, an expensive recall campaign, deep job cuts, and a simplified but beleaguered share structure. The capital markets day in late September now looms as the pivotal moment when management must convince the market that the company has a credible path back to profitability. Until then, the stock appears likely to remain range-bound near its lows, with the outcome of that presentation determining whether the recent stabilization marks a genuine floor or merely a pause before further declines.
